The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 07, 2014
Filed:
Dec. 23, 2008
Ulrich Klar, Berlin, DE;
Joachim Kuhnke, Potsdam, DE;
Rolf Bohlmann, Berlin, DE;
Jan Hübner, Berlin, DE;
Sven Ring, Jena, DE;
Thomas Frenzel, Hofheim, DE;
Frederik Menges, Schriesheim, DE;
Steffen Borden, Berlin, DE;
Hans-peter Muhn, Berlin, DE;
Katja Prelle, Berlin, DE;
Ulrich Klar, Berlin, DE;
Joachim Kuhnke, Potsdam, DE;
Rolf Bohlmann, Berlin, DE;
Jan Hübner, Berlin, DE;
Sven Ring, Jena, DE;
Thomas Frenzel, Hofheim, DE;
Frederik Menges, Schriesheim, DE;
Steffen Borden, Berlin, DE;
Hans-Peter Muhn, Berlin, DE;
Katja Prelle, Berlin, DE;
Bayer Intellectual Property GmbH, Monheim, DE;
Abstract
The invention relates to 15,16-methylene-17-(1'-propenyl)-17-3′-oxidoestra-4-en-3-one derivatives with the general chemical formula I, where the Z, R, R, R, Rand Rhave the meanings stated in claim, and solvates, hydrates and salts thereof, including all crystal modifications and all stereoisomers of these compounds. The invention also relates to the use of these derivatives for the production of a drug for oral contraception and for the treatment of pre-, peri- and postmenopausal problems and drugs which contain such derivatives, in particular use in the aforesaid indications. The derivatives according to the invention have a progestational and in preferable cases also an antimineralcorticoid and neutral to slight androgenic activity.